CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 9 of 15

Annals of the Rheumatic Diseases

Briefs 321–360 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study

    Cohort studyOsteoarthritis

  2. Ann Rheum Dis

    Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial

    Randomized controlled trialRA

  3. Ann Rheum Dis

    Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research

    Guideline or statementPediatric

  4. Ann Rheum Dis

    Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study

    Cohort studyRA

  5. Ann Rheum Dis

    EULAR recommendations for the treatment of systemic sclerosis: 2023 update

    Guideline or statementSystemic sclerosis

  6. Ann Rheum Dis

    Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China

    Randomized controlled trialLupus & APS

  7. Ann Rheum Dis

    Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults

    Guideline or statementAutoinflammatory & rare

  8. Ann Rheum Dis

    Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages

    Case-control studySystemic sclerosis

  9. Ann Rheum Dis

    Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial

    Randomized controlled trialRA

  10. Ann Rheum Dis

    ITGA5+ synovial fibroblasts orchestrate proinflammatory niche formation by remodelling the local immune microenvironment in rheumatoid arthritis

    Mechanistic studyRA

  11. Ann Rheum Dis

    Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders

    Mechanistic studyLupus & APS

  12. Ann Rheum Dis

    Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis

    Diagnostic or prognostic studySpondyloarthritis & PsA

  13. Ann Rheum Dis

    Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness

    Cohort studyRA

  14. Ann Rheum Dis

    Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy

    Mechanistic studyMyositis

  15. Ann Rheum Dis

    Predicting rapid progression in knee osteoarthritis: a novel and interpretable automated machine learning approach, with specific focus on young patients and early disease

    Diagnostic or prognostic studyOsteoarthritis

  16. Ann Rheum Dis

    Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

    Cohort studySpondyloarthritis & PsA

  17. Ann Rheum Dis

    Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis

    Cohort studyVasculitis & PMR

  18. Ann Rheum Dis

    Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis

    Research articleGout & crystals

  19. Ann Rheum Dis

    Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis

    Research articleSystemic sclerosis

  20. Ann Rheum Dis

    Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk

    Case-control studyRA

  21. Ann Rheum Dis

    Vascular occlusion for optimising the functional improvement in patients with knee osteoarthritis: a randomised controlled trial

    Randomized controlled trialOsteoarthritis

  22. Ann Rheum Dis

    Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

    Secondary analysisRA

  23. Ann Rheum Dis

    Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)

    Guideline or statementSpondyloarthritis & PsA

  24. Ann Rheum Dis

    Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration

    Guideline or statementSpondyloarthritis & PsA

  25. Ann Rheum Dis

    Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?

    Cohort studyRA

  26. Ann Rheum Dis

    Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease

    Meta-analysisAutoinflammatory & rare

  27. Ann Rheum Dis

    EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease

    Guideline or statementPediatric

  28. Ann Rheum Dis

    Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis

    Mechanistic studyRA

  29. Ann Rheum Dis

    Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

    Meta-analysisSpondyloarthritis & PsA

  30. Ann Rheum Dis

    Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease

    Cross-sectional studyAutoinflammatory & rare

  31. Ann Rheum Dis

    Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development

    Mechanistic studyRA

  32. Ann Rheum Dis

    Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study

    Mechanistic studyRA

  33. Ann Rheum Dis

    Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease

    Meta-analysisPediatric

  34. Ann Rheum Dis

    EULAR points to consider for patient education in physical activity and self-management of pain during transitional care

    Guideline or statementPediatric

  35. Ann Rheum Dis

    Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study

    Cross-sectional studyRA

  36. Ann Rheum Dis

    Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

    Research articleAcross diseases

  37. Ann Rheum Dis

    Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking

    Mechanistic studyRA

  38. Ann Rheum Dis

    Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease

    Mechanistic studySjögren's & overlap

  39. Ann Rheum Dis

    Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis

    Mechanistic studySystemic sclerosis

  40. Ann Rheum Dis

    Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures

    Cross-sectional studySystemic sclerosis

All 596 Briefs in ExploreShowing Briefs 321–360 of 596, newest first